{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:11:58Z","timestamp":1793502718899,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijid.2024.107321","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:39:37Z","timestamp":1732937977000},"page":"107321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Emergence of cefiderocol resistance during therapy in NDM-5\u2013producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations"],"prefix":"10.1016","volume":"151","author":[{"given":"Luc","family":"Deroche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albane","family":"Rozenholc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Arriv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-7699","authenticated-orcid":false,"given":"Jean-Philippe","family":"Martellosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl Le","family":"Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud W.","family":"Thille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-4654","authenticated-orcid":false,"given":"Julien M.","family":"Buyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107321_bib0001","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107321_bib0002","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Guidance document on broth microdilution testing of cefiderocol, https:\/\/www.eucast.org\/eucastguidancedocuments; 2024 [accessed 20 November 2024]."},{"key":"10.1016\/j.ijid.2024.107321_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijid.2021.09.031","article-title":"Usefulness of Xpert\u00ae Carba-R on enrichment broth for the early detection of carbapenemase-producing Enterobacterales","volume":"112","author":"Girlich","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107321_bib0004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijid.2024.107321_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2024.107321_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01779-21","article-title":"In vitro evolution of cefiderocol resistance in an NDM-producing Klebsiella pneumoniae due to functional loss of CirA","volume":"9","author":"McElheny","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2024.107321_bib0007","article-title":"Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in china: a report from china CRE-network","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2024.107321_bib0008","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.43.2200795","article-title":"Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022","volume":"27","author":"Coppi","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2024.107321_bib0009","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciab511","article-title":"Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae During therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA","volume":"74","author":"Klein","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107321_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106635","article-title":"Cefiderocol heteroresistance in Klebsiella pneumoniae is linked to mutations in the siderophore receptor cirA and \u03b2-lactamase activities","volume":"60","author":"Moon","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2024.107321_bib0011","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cmi.2023.11.005","article-title":"In vivo evolution to high-level cefiderocol resistance of NDM-1\u2013producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission","volume":"30","author":"Tascini","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107321_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00084-22","article-title":"Emergence of high-level cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in patients with hematologic malignancies in china","volume":"10","author":"Lan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2024.107321_bib0013","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/jac\/dkad004","article-title":"Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor","volume":"78","author":"Jousset","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.107321_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01507-23","article-title":"A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance","volume":"68","author":"Freiberg","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2024.107321_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/cid\/ciab888","article-title":"Progressive development of cefiderocol resistance in Escherichia coli During therapy is associated with increased blaNDM-5 copy number and gene expression","volume":"75","author":"Simner","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107321_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.04.013","article-title":"Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales","volume":"28","author":"Bonnin","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107321_bib0017","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jac\/dkad149","article-title":"Performance evaluation of the UMIC\u00ae Cefiderocol to determine MIC in Gram-negative bacteria","volume":"78","author":"Dortet","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.107321_bib0018","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/jac\/dkad134","article-title":"Comparison of ComASP\u00ae and UMIC\u00ae methods with the reference method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales","volume":"78","author":"Emeraud","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.107321_bib0019","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107321_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107321_bib0021","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/antibiotics10060652","article-title":"Cefiderocol-based combination therapy for \u201cdifficult-to-treat\u201d Gram-negative severe infections: real-life case series and future perspectives","volume":"10","author":"Bavaro","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijid.2024.107321_bib0022","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/mdr.2021.0180","article-title":"Mechanisms of reduced susceptibility to cefiderocol among isolates from the CREDIBLE-CR and APEKS-NP clinical trials","volume":"28","author":"Nordmann","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijid.2024.107321_bib0023","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cmi.2021.04.016","article-title":"Cross-resistance to cefiderocol and ceftazidime\u2013avibactam in KPC \u03b2-lactamase mutants and the inoculum effect","volume":"27","author":"Hobson","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224003965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T20:39:18Z","timestamp":1741293558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224003965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"alternative-id":["S1201971224003965"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107321","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of cefiderocol resistance during therapy in NDM-5\u2013producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107321"}}